Amyotrophic lateral sclerosis models and human neuropathology: similarities and differences

被引:111
作者
Kato, Shinsuke [1 ]
机构
[1] Tottori Univ, Fac Med, Inst Neurol Sci, Dept Neuropathol, Yonago, Tottori 6838504, Japan
关键词
amyotrophic lateral sclerosis; animal models; superoxide dismutase 1; transgenic rodents; human pathology;
D O I
10.1007/s00401-007-0308-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that primarily involves the motor neuron system. The author initially summarizes the principal features of human ALS neuropathology, and subsequently describes in detail ALS animal models mainly from the viewpoint of pathological similarities and differences. ALS animal models in this review include strains of rodents that are transgenic for superoxide dismutase 1 (SOD1), ALS2 knockout mice, and mice that are transgenic for cytoskeletal abnormalities. Although the neuropathological results obtained from human ALS autopsy cases are valuable and important, almost all of such cases represent only the terminal stage. This makes it difficult to clarify how and why ALS motor neurons are impaired at each clinical stage from disease onset to death, and as a consequence, human autopsy cases alone yield little insight into potential therapies for ALS. Although ALS animal models cannot replicate human ALS, in order to compensate for the shortcomings of studies using human ALS autopsy samples, researchers must inevitably rely on ALS animal models that can yield very important information for clarifying the pathogenesis of ALS in humans and for the establishment of reliable therapy. Of course, human ALS and all ALS animal models share one most important similarity in that both exhibit motor neuron degeneration/death. This important point of similarity has shed much light on the pathomechanisms of the motor neuron degeneration/death at the cellular and molecular levels that would not have been appreciated if only human ALS autopsy samples had been available. On the basis of the aspects covered in this review, it can be concluded that ALS animal models can yield very important information for clarifying the pathogenesis of ALS in humans and for the establishment of reliable therapy only in combination with detailed neuropathological data obtained from human ALS autopsy cases.
引用
收藏
页码:97 / 114
页数:18
相关论文
共 105 条
[61]  
Kong JM, 1998, J NEUROSCI, V18, P3241
[62]   Novel mutation in the ALS2 gene in juvenile amyotrophic lateral sclerosis [J].
Kress, JA ;
Kühnlein, P ;
Winter, P ;
Ludolph, AC ;
Kassubek, J ;
Müller, U ;
Sperfeld, AD .
ANNALS OF NEUROLOGY, 2005, 58 (05) :800-803
[63]   Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration [J].
LaMonte, BH ;
Wallace, KE ;
Holloway, BA ;
Shelly, SS ;
Ascaño, J ;
Tokito, M ;
Van Winkle, T ;
Howland, DS ;
Holzbaur, ELF .
NEURON, 2002, 34 (05) :715-727
[64]   A MUTANT NEUROFILAMENT SUBUNIT CAUSES MASSIVE, SELECTIVE MOTOR-NEURON DEATH - IMPLICATIONS FOR THE PATHOGENESIS OF HUMAN MOTOR-NEURON DISEASE [J].
LEE, MK ;
MARSZALEK, JR ;
CLEVELAND, DW .
NEURON, 1994, 13 (04) :975-988
[65]   Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease [J].
Lino, MM ;
Schneider, C ;
Caroni, P .
JOURNAL OF NEUROSCIENCE, 2002, 22 (12) :4825-4832
[66]   Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis [J].
Miller, Timothy M. ;
Kim, Soo H. ;
Yamanaka, Koji ;
Hester, Mark ;
Umapathi, Priya ;
Arnson, Hannah ;
Rizo, Liza ;
Mendell, Jerry R. ;
Gage, Fred H. ;
Cleveland, Don W. ;
Kaspar, Brian K. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (51) :19546-19551
[67]  
Mochizuki Yoko, 2003, Rinsho Shinkeigaku, V43, P491
[68]  
Morrison BM, 1996, J COMP NEUROL, V373, P619, DOI 10.1002/(SICI)1096-9861(19960930)373:4<619::AID-CNE9>3.0.CO
[69]  
2-4
[70]   The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu,Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease [J].
Mourelatos, Z ;
Gonatas, NK ;
Stieber, A ;
Gurney, ME ;
DalCanto, MC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (11) :5472-5477